---
category: news
title: "Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target"
excerpt: "Kiromic Biopharma, Inc. (NASDAQ:KRBP), a target discovery and gene-editing company utilizing artificial intelligence and proprietary neural network platform with a"
publishedDateTime: 2021-01-05T01:35:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/01/b19011075/kiromic-announces-the-filing-of-key-european-patents-for-its-chimeric-pd-1-chpd1-target"
webUrl: "https://www.benzinga.com/pressreleases/21/01/b19011075/kiromic-announces-the-filing-of-key-european-patents-for-its-chimeric-pd-1-chpd1-target"
ampWebUrl: "https://amp.benzinga.com/amp/content/19011075"
cdnAmpWebUrl: "https://amp-benzinga-com.cdn.ampproject.org/c/s/amp.benzinga.com/amp/content/19011075"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

secured: "+lSpfMTajA+IUPSpjfnjofXa6mdUeEJRgoUpicr+Q+bKCPH7WAKHYuPeVwaYFTkGxz1FJJkAA8iTyW2XSMiU7nBLVaNkJWMPRXcW+rqk+UvrA6ciYIeAwMRvrQ7tSkOu/15xKmF7sQ3zeOqTYOsrC/5eRMzUdPycppkIeJcc7K+9wnhDy6JP9SLGbgd9/1mVE9x81cpbSn1yN0lDEeEYX4U/OdGiFpOFeG61LQKxIgr6JOgpwaDI+w2qXpdZAtMYjM9VZIHoLyAwGv5mcSnvzdm6QfFVNBNN4jsAR/nUGC7sq8oGpCP4vGQnj7pJQ+hBRUHRtJjm6syfQaUEET36kqDCI81WrPAKhrpxztFdBRg=;JhQuwMHsYFTAOSJ33AbDPQ=="
---

